Trial · NCT00796666
Results by group80
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 80
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to Clinical Worsening (TTCW) | Sitaxsentan and Placebo | NA | Full Range 123 to 356 | Days | |
| Time to Clinical Worsening (TTCW) | Sitaxsentan and Sildenafil | NA | Full Range 119 to 409 | Days | |
| Change From Baseline in the Total Distance Walked During 6 Minute Walk Distance (6MWD) | Sitaxsentan and Placebo | Baseline | 350.9 | Standard Deviation 74.47 | meters (m) |
| Change From Baseline in the Total Distance Walked During 6 Minute Walk Distance (6MWD) | Sitaxsentan and Sildenafil | Baseline | 354.7 | Standard Deviation 79.88 | meters (m) |
| Change From Baseline in the Total Distance Walked During 6 Minute Walk Distance (6MWD) | Sitaxsentan and Placebo | Change at Week 12 | -6.9 | Standard Deviation 71.00 | meters (m) |
| Change From Baseline in the Total Distance Walked During 6 Minute Walk Distance (6MWD) | Sitaxsentan and Sildenafil | Change at Week 12 | 23.2 | Standard Deviation 56.49 | meters (m) |
| Change From Baseline in the Total Distance Walked During 6 Minute Walk Distance (6MWD) | Sitaxsentan and Placebo | Change at Week 24 | -5.4 | Standard Deviation 62.74 | meters (m) |
| Change From Baseline in the Total Distance Walked During 6 Minute Walk Distance (6MWD) | Sitaxsentan and Sildenafil | Change at Week 24 | 17.5 | Standard Deviation 66.84 | meters (m) |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Placebo | Week 12 Improvement | 14 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Sildenafil | Week 12 Improvement | 14 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Placebo | Week 12 No Change | 52 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Sildenafil | Week 12 No Change | 49 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Placebo | Week 12 Deterioration | 1 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Sildenafil | Week 12 Deterioration | 1 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Placebo | Week 24 Improvement | 13 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Sildenafil | Week 24 Improvement | 16 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Placebo | Week 24 No Change | 53 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Sildenafil | Week 24 No Change | 47 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Placebo | Week 24 Deterioration | 1 | participant | |
| Change From Baseline in World Health Organization (WHO) Functional Class in Participants With PAH at Weeks 12, 24, 48 | Sitaxsentan and Sildenafil | Week 24 Deterioration | 1 | participant |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00796666/results